{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T11:40:40Z","timestamp":1695210040021},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00393-019-00687-0","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T10:04:21Z","timestamp":1567591461000},"page":"955-966","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Was sind die Indikationen f\u00fcr Rescue-Verfahren?","What are the indications for rescue procedures?"],"prefix":"10.1007","volume":"78","author":[{"given":"B.","family":"Hellmich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"687_CR1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MAT.0000000000000183","volume":"61","author":"D Abrams","year":"2015","unstructured":"Abrams\u00a0D, Agerstrand\u00a0CL, Biscotti\u00a0M et\u00a0al (2015) Extracorporeal membrane oxygenation in the management of diffuse alveolar hemorrhage. ASAIO\u00a0J 61:216\u2013218","journal-title":"ASAIO J"},{"key":"687_CR2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ajh.21795","volume":"85","author":"JS Ahn","year":"2010","unstructured":"Ahn\u00a0JS, Rew\u00a0SY, Shin\u00a0MG et al (2010) Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 85:719\u2013722","journal-title":"Am J Hematol"},{"key":"687_CR3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ndt\/gfu399","volume":"30","author":"B Alchi","year":"2015","unstructured":"Alchi\u00a0B, Griffiths\u00a0M, Sivalingam\u00a0M et al (2015) Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a\u00a0two-centre cohort. Nephrol Dial Transplant 30:814\u2013821","journal-title":"Nephrol Dial Transplant"},{"key":"687_CR4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12890-016-0214-4","volume":"16","author":"HS Ali","year":"2016","unstructured":"Ali\u00a0HS, Hassan\u00a0IF, George\u00a0S (2016) Extra corporeal membrane oxygenation to facilitate lung protective ventilation and prevent ventilator-induced lung injury in severe pneumocystis pneumonia with pneumomediastinum: a\u00a0case report and short literature review. BMC Pulm Med 16:52","journal-title":"BMC Pulm Med"},{"key":"687_CR5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/CRIAI:29:3:237","volume":"29","author":"PM Aries","year":"2005","unstructured":"Aries\u00a0PM, Hellmich\u00a0B, Gross\u00a0WL (2005) Intravenous immunoglobulin therapy in vasculitis: speculation or evidence? Clin Rev Allergy Immunol 29:237\u2013245","journal-title":"Clin Rev Allergy Immunol"},{"key":"687_CR6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","volume":"12","author":"RA Asherson","year":"2003","unstructured":"Asherson\u00a0RA, Cervera\u00a0R, De Groot\u00a0PG et\u00a0al (2003) Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12:530\u2013534","journal-title":"Lupus"},{"key":"687_CR7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00296-016-3545-9","volume":"36","author":"S Aytac","year":"2016","unstructured":"Aytac\u00a0S, Batu\u00a0ED, Unal\u00a0S et\u00a0al (2016) Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int 36:1421\u20131429","journal-title":"Rheumatol Int"},{"key":"687_CR8","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMct1103720","volume":"365","author":"D Brodie","year":"2011","unstructured":"Brodie\u00a0D, Bacchetta\u00a0M (2011) Extracorporeal membrane oxygenation for ARDS in adults. N\u00a0Engl J Med 365:1905\u20131914","journal-title":"N Engl J Med"},{"key":"687_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anpedi.2011.12.011","volume":"77","author":"BR Bustos","year":"2012","unstructured":"Bustos\u00a0BR, Carrasco\u00a0AC, Toledo\u00a0RC (2012) Plasmapheresis for macrophage activation syndrome and multiorgan failure as first presentation of juvenile dermatomyositis. An Pediatr (Barc) 77:47\u201350","journal-title":"An Pediatr (Barc)"},{"key":"687_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1191\/0961203305lu2082oa","volume":"14","author":"JF Camargo","year":"2005","unstructured":"Camargo\u00a0JF, Tobon\u00a0GJ, Fonseca\u00a0N et\u00a0al (2005) Autoimmune rheumatic diseases in the intensive care unit: experience from a\u00a0tertiary referral hospital and review of the literature. Lupus 14:315\u2013320","journal-title":"Lupus"},{"key":"687_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/path.1711550110","volume":"155","author":"SJ Cashman","year":"1988","unstructured":"Cashman\u00a0SJ, Pusey\u00a0CD, Evans\u00a0DJ (1988) Extraglomerular distribution of immunoreactive Goodpasture antigen. J\u00a0Pathol 155:61\u201370","journal-title":"J Pathol"},{"key":"687_CR12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/RHU.0b013e3181ffe517","volume":"16","author":"JA Cavallasca","year":"2010","unstructured":"Cavallasca\u00a0JA, Del Rosario Maliandi\u00a0M, Sarquis\u00a0S et\u00a0al (2010) Outcome of patients with systemic rheumatic diseases admitted to a\u00a0medical intensive care unit. J\u00a0Clin Rheumatol 16:400\u2013402","journal-title":"J Clin Rheumatol"},{"key":"687_CR13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2016.06.009","volume":"90","author":"WF Clark","year":"2016","unstructured":"Clark\u00a0WF, Huang\u00a0SS, Walsh\u00a0MW et\u00a0al (2016) Plasmapheresis for the treatment of kidney diseases. Kidney Int 90:974\u2013984","journal-title":"Kidney Int"},{"key":"687_CR14","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A Combes","year":"2018","unstructured":"Combes\u00a0A, Hajage\u00a0D, Capellier\u00a0G et\u00a0al (2018) Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N\u00a0Engl J Med 378:1965\u20131975","journal-title":"N Engl J Med"},{"key":"687_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MD.0b013e31822f6f68","volume":"90","author":"Z Cui","year":"2011","unstructured":"Cui\u00a0Z, Zhao\u00a0J, Jia\u00a0XY et al (2011) Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a\u00a0large single-center Chinese cohort study. Medicine (Baltimore) 90:303\u2013311","journal-title":"Medicine (Baltimore)"},{"key":"687_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1051\/ject\/201244075","volume":"44","author":"A Dalabih","year":"2012","unstructured":"Dalabih\u00a0A, Pietsch\u00a0J, Jabs\u00a0K et\u00a0al (2012) Extracorporeal membrane oxygenation as a\u00a0platform for recovery: a\u00a0case report of a\u00a0child with pulmonary hemorrhage, refractory hypoxemic respiratory failure, and new onset goodpasture syndrome. J\u00a0Extra Corpor Technol 44:75\u201377","journal-title":"J Extra Corpor Technol"},{"key":"687_CR17","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas\u00a0MC, Illa\u00a0I, Dambrosia\u00a0JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N\u00a0Engl J Med 329:1993\u20132000","journal-title":"N Engl J Med"},{"key":"687_CR18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2009.04.003","volume":"9","author":"MG Danieli","year":"2009","unstructured":"Danieli\u00a0MG, Calcabrini\u00a0L, Calabrese\u00a0V et\u00a0al (2009) Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. Autoimmun Rev 9:124\u2013127","journal-title":"Autoimmun Rev"},{"key":"687_CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00296-018-4116-z","volume":"39","author":"P Delvino","year":"2019","unstructured":"Delvino\u00a0P, Monti\u00a0S, Balduzzi\u00a0S et al (2019) The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis: report of two cases and review of the literature. Rheumatol Int 39:367\u2013375","journal-title":"Rheumatol Int"},{"key":"687_CR20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/BOR.0000000000000390","volume":"29","author":"AC Desbois","year":"2017","unstructured":"Desbois\u00a0AC, Comarmond\u00a0C, Saadoun\u00a0D et\u00a0al (2017) Cryoglobulinemia vasculitis: how to handle. Curr Opin Rheumatol 29:343\u2013347","journal-title":"Curr Opin Rheumatol"},{"key":"687_CR21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","volume":"72","author":"N Duru","year":"2013","unstructured":"Duru\u00a0N, Van Der Goes\u00a0MC, Jacobs\u00a0JW et al (2013) EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 72:1905\u20131913","journal-title":"Ann Rheum Dis"},{"key":"687_CR22","first-page":"Cd007057","volume":"1","author":"PM Fortin","year":"2013","unstructured":"Fortin\u00a0PM, Tejani\u00a0AM, Bassett\u00a0K et\u00a0al (2013) Intravenous immunoglobulin as adjuvant therapy for Wegener\u2019s granulomatosis. Cochrane Database Syst Rev 1:Cd7057","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"687_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00277-010-0950-0","volume":"89","author":"JD Grainger","year":"2010","unstructured":"Grainger\u00a0JD, Bolton-Maggs\u00a0PH, Godeau\u00a0B et al (2010) Diagnosis and management of chronic ITP: comments from an ICIS expert group. Ann Hematol 89(Suppl 1):11\u201317","journal-title":"Ann Hematol"},{"key":"687_CR24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.1780350214","volume":"35","author":"L Guillevin","year":"1992","unstructured":"Guillevin\u00a0L, Fain\u00a0O, Lhote\u00a0F et al (1992) Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteriitis nodosa and Churg-Strauss syndrome. A\u00a0prospective, randomized trial in 78 patients. Arthritis Rheum 35:208\u2013215","journal-title":"Arthritis Rheum"},{"key":"687_CR25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-67-2-393","volume":"67","author":"D Hollander","year":"1967","unstructured":"Hollander\u00a0D, Manning\u00a0R (1967) The use of alcylating agents in the treatment of Wegener\u2019s granulomatosis. Ann Intern Med 67:393\u2013398","journal-title":"Ann Intern Med"},{"key":"687_CR26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2016.05.015","volume":"73","author":"A Huart","year":"2016","unstructured":"Huart\u00a0A, Josse\u00a0AG, Chauveau\u00a0D et al (2016) Outcomes of patients with Goodpasture syndrome: a nationwide cohort-based study from the French Society of Hemapheresis. J\u00a0Autoimmun 73:24\u201329","journal-title":"J Autoimmun"},{"key":"687_CR27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0749-0704(02)00025-8","volume":"18","author":"NM Janssen","year":"2002","unstructured":"Janssen\u00a0NM, Karnad\u00a0DR, Guntupalli\u00a0KK (2002) Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin 18:729\u2013748","journal-title":"Crit Care Clin"},{"key":"687_CR28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"DR Jayne","year":"2000","unstructured":"Jayne\u00a0DR, Chapel\u00a0H, Adu\u00a0D et al (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433\u2013439","journal-title":"QJM"},{"key":"687_CR29","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DR Jayne","year":"2007","unstructured":"Jayne\u00a0DR, Gaskin\u00a0G, Rasmussen\u00a0N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J\u00a0Am Soc Nephrol 18:2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"687_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette\u00a0JC, Falk\u00a0RJ, Bacon\u00a0PA et\u00a0al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"687_CR31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","volume":"64","author":"JP Johnson","year":"1985","unstructured":"Johnson\u00a0JP, Moore\u00a0J Jr., Austin\u00a0HA 3rd et al (1985) Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore) 64:219\u2013227","journal-title":"Medicine (Baltimore)"},{"key":"687_CR32","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/14397595.2013.844402","volume":"25","author":"S Kaieda","year":"2015","unstructured":"Kaieda\u00a0S, Yoshida\u00a0N, Yamashita\u00a0F et\u00a0al (2015) Successful treatment of macrophage activation syndrome in a\u00a0patient with dermatomyositis by combination with immunosuppressive therapy and plasmapheresis. Mod Rheumatol 25:962\u2013966","journal-title":"Mod Rheumatol"},{"key":"687_CR33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jca.21441","volume":"31","author":"A Kaplan","year":"2016","unstructured":"Kaplan\u00a0A, Raut\u00a0P, Totoe\u00a0G et\u00a0al (2016) Management of systemic unfractionated heparin anticoagulation during therapeutic plasma exchange. J\u00a0Clin Apher 31:507\u2013515","journal-title":"J Clin Apher"},{"key":"687_CR34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2141.1978.tb01078.x","volume":"38","author":"AJ Keller","year":"1978","unstructured":"Keller\u00a0AJ, Urbaniak\u00a0SJ (1978) Intensive plasma exchange on the cell separator: effects on serum immunoglobulins and complement components. Br J Haematol 38:531\u2013540","journal-title":"Br J Haematol"},{"key":"687_CR35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autrev.2015.08.010","volume":"15","author":"A Kronbichler","year":"2016","unstructured":"Kronbichler\u00a0A, Brezina\u00a0B, Quintana\u00a0LF et\u00a0al (2016) Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review. Autoimmun Rev 15:38\u201349","journal-title":"Autoimmun Rev"},{"key":"687_CR36","first-page":"533","volume":"151","author":"C Larroche","year":"2000","unstructured":"Larroche\u00a0C, Bruneel\u00a0F, Andre\u00a0MH et al (2000) Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP. Ann Med Interne (Paris) 151:533\u2013539","journal-title":"Ann Med Interne (Paris)"},{"key":"687_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14192","author":"K Legault","year":"2018","unstructured":"Legault\u00a0K, Schunemann\u00a0H, Hillis\u00a0C et al (2018) McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome. J\u00a0Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14192","journal-title":"J Thromb Haemost"},{"key":"687_CR38","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1084\/jem.126.6.989","volume":"126","author":"RA Lerner","year":"1967","unstructured":"Lerner\u00a0RA, Glassock\u00a0RJ, Dixon\u00a0FJ (1967) The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J\u00a0Exp Med 126:989\u20131004","journal-title":"J Exp Med"},{"key":"687_CR39","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","volume":"134","author":"JB Levy","year":"2001","unstructured":"Levy\u00a0JB, Turner\u00a0AN, Rees\u00a0AJ et al (2001) Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033\u20131042","journal-title":"Ann Intern Med"},{"key":"687_CR40","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJM199205213262101","volume":"326","author":"EJ Lewis","year":"1992","unstructured":"Lewis\u00a0EJ, Hunsicker\u00a0LG, Lan\u00a0SP et\u00a0al (1992) A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N\u00a0Engl J Med 326:1373\u20131379","journal-title":"N Engl J Med"},{"key":"687_CR41","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(76)93089-0","volume":"1","author":"CM Lockwood","year":"1976","unstructured":"Lockwood\u00a0CM, Rees\u00a0AJ, Pearson\u00a0TA et al (1976) Immunosuppression and plasma-exchange in the treatment of Goodpasture\u2019s syndrome. Lancet 1:711\u2013715","journal-title":"Lancet"},{"key":"687_CR42","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.transci.2018.06.005","volume":"57","author":"P Marson","year":"2018","unstructured":"Marson\u00a0P, Monti\u00a0G, Montani\u00a0F et\u00a0al (2018) Apheresis treatment of cryoglobulinemic vasculitis: a multicentre cohort study of 159 patients. Transfus Apher Sci 57:639\u2013645","journal-title":"Transfus Apher Sci"},{"key":"687_CR43","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2215\/CJN.01380217","volume":"12","author":"SP Mcadoo","year":"2017","unstructured":"Mcadoo\u00a0SP, Pusey\u00a0CD (2017) Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol 12:1162\u20131172","journal-title":"Clin J Am Soc Nephrol"},{"key":"687_CR44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","volume":"92","author":"SP Mcadoo","year":"2017","unstructured":"Mcadoo\u00a0SP, Tanna\u00a0A, Hruskova\u00a0Z et al (2017) Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int 92:693\u2013702","journal-title":"Kidney Int"},{"key":"687_CR45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3899\/jrheum.150376","volume":"43","author":"L Mcgeoch","year":"2016","unstructured":"Mcgeoch\u00a0L, Twilt\u00a0M, Famorca\u00a0L et al (2016) CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides. J\u00a0Rheumatol 43:97\u2013120","journal-title":"J Rheumatol"},{"key":"687_CR46","unstructured":"Medicine OCFE\u2011B (2009) Oxford Centre for Evidence-based Medicine\u2014Levels of Evidence (March 2009). https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/ . Zugegriffen: 8.\u00a0Aug 2019"},{"key":"687_CR47","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1164\/rccm.201511-2184ED","volume":"193","author":"O Moerer","year":"2016","unstructured":"Moerer\u00a0O, Quintel\u00a0M (2016) Bridge or abyss: extracorporeal membrane oxygenation for acute respiratory failure in interstitial lung disease. Am J Respir Crit Care Med 193:474\u2013476","journal-title":"Am J Respir Crit Care Med"},{"key":"687_CR48","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/TA.0b013e31824d68e3","volume":"72","author":"RM Muellenbach","year":"2012","unstructured":"Muellenbach\u00a0RM, Kredel\u00a0M, Kunze\u00a0E et al (2012) Prolonged heparin-free extracorporeal membrane oxygenation in multiple injured acute respiratory distress syndrome patients with traumatic brain injury. J\u00a0Trauma Acute Care Surg 72:1444\u20131447","journal-title":"J Trauma Acute Care Surg"},{"key":"687_CR49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/asheducation-2018.1.568","volume":"2018","author":"CE Neunert","year":"2018","unstructured":"Neunert\u00a0CE, Cooper\u00a0N (2018) Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematology Am Soc Hematol Educ Program 2018:568\u2013575","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"687_CR50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","volume":"315","author":"JW Newburger","year":"1986","unstructured":"Newburger\u00a0JW, Takahashi\u00a0M, Burns\u00a0JC et\u00a0al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N\u00a0Engl J Med 315:341\u2013347","journal-title":"N Engl J Med"},{"key":"687_CR51","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki\u00a0E, Carruthers\u00a0D, Chakravarty\u00a0K et al (2014) BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatol (Oxford) 53:2306\u20132309. https:\/\/doi.org\/10.1093\/rheumatology\/ket445","journal-title":"Rheumatol (Oxford)"},{"key":"687_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14400","author":"AR Peedin","year":"2019","unstructured":"Peedin\u00a0AR, Karp\u00a0JK (2019) Revisiting the role of therapeutic plasma exchange in the management of catastrophic antiphospholipid syndrome. J\u00a0Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14400","journal-title":"J Thromb Haemost"},{"key":"687_CR53","first-page":"435","volume":"52","author":"AJ Pinching","year":"1983","unstructured":"Pinching\u00a0AJ, Lockwood\u00a0CM, Pussell\u00a0BA et\u00a0al (1983) Wegener\u2019s granulomatosis: observations on 18 patients with severe renal disease. Q\u00a0J Med 52:435\u2013460","journal-title":"Q J Med"},{"key":"687_CR54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.autrev.2012.06.002","volume":"12","author":"OL Quintero","year":"2013","unstructured":"Quintero\u00a0OL, Rojas-Villarraga\u00a0A, Mantilla\u00a0RD et al (2013) Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev 12:380\u2013395","journal-title":"Autoimmun Rev"},{"key":"687_CR55","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"J Radhakrishnan","year":"2012","unstructured":"Radhakrishnan\u00a0J, Cattran\u00a0DC (2012) The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines\u2014application to the individual patient. Kidney Int 82:840\u2013856","journal-title":"Kidney Int"},{"key":"687_CR56","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jhep.2017.02.010","volume":"66","author":"M Ramos-Casals","year":"2017","unstructured":"Ramos-Casals\u00a0M, Zignego\u00a0AL, Ferri\u00a0C et al (2017) Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. J\u00a0Hepatol 66:1282\u20131299","journal-title":"J Hepatol"},{"key":"687_CR57","first-page":"00168","volume":"10","author":"DM Roberts","year":"2015","unstructured":"Roberts\u00a0DM, Jones\u00a0RB, Smith\u00a0RM et al (2015) Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series. J\u00a0Autoimmun 10:168\u2013161","journal-title":"J Autoimmun"},{"key":"687_CR58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2010.03.001","volume":"42","author":"MA Rockx","year":"2010","unstructured":"Rockx\u00a0MA, Clark\u00a0WF (2010) Plasma exchange for treating cryoglobulinemia: a\u00a0descriptive analysis. Transfus Apher Sci 42:247\u2013251","journal-title":"Transfus Apher Sci"},{"issue":"Suppl 1","key":"687_CR59","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/S1590-8658(07)80027-2","volume":"39","author":"S Scarpato","year":"2007","unstructured":"Scarpato\u00a0S, Tirri\u00a0E, Naclerio\u00a0C et\u00a0al (2007) Plasmapheresis in cryoglobulinemic neuropathy: a\u00a0clinical study. Dig Liver Dis 39(Suppl 1):S136\u2013S137","journal-title":"Dig Liver Dis"},{"key":"687_CR60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00393-017-0394-1","volume":"76","author":"JH Schirmer","year":"2017","unstructured":"Schirmer\u00a0JH, Aries\u00a0PM, De Groot\u00a0K et al (2017) S 1 Leitlinie zur Diagnose und Therapie der ANCA-assoziierten Vaskulitiden. Z\u00a0Rheumatol 76:77\u2013104","journal-title":"Z Rheumatol"},{"key":"687_CR61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12882-017-0803-3","volume":"19","author":"JJ Schmidt","year":"2018","unstructured":"Schmidt\u00a0JJ, Asper\u00a0F, Einecke\u00a0G et al (2018) Therapeutic plasma exchange in a\u00a0tertiary care center: 185 patients undergoing 912 treatments\u2014a\u00a0one-year retrospective analysis. BMC Nephrol 19:12","journal-title":"BMC Nephrol"},{"key":"687_CR62","first-page":"149","volume":"31","author":"J Schwartz","year":"2016","unstructured":"Schwartz\u00a0J, Padmanabhan\u00a0A, Aqui\u00a0N et al (2016) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue. J\u00a0Clin Apher 31:149\u2013162","journal-title":"J Clin Apher"},{"key":"687_CR63","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","volume":"22","author":"D Shemin","year":"2007","unstructured":"Shemin\u00a0D, Briggs\u00a0D, Greenan\u00a0M (2007) Complications of therapeutic plasma exchange: a\u00a0prospective study of 1,727 procedures. J\u00a0Clin Apher 22:270\u2013276","journal-title":"J Clin Apher"},{"key":"687_CR64","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jca.20222","volume":"24","author":"C Stefanutti","year":"2009","unstructured":"Stefanutti\u00a0C, Vivenzio\u00a0A, Di Giacomo\u00a0S et al (2009) Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia. J\u00a0Clin Apher 24:241\u2013246","journal-title":"J Clin Apher"},{"key":"687_CR65","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.201508-1701OC","volume":"193","author":"FC Trudzinski","year":"2016","unstructured":"Trudzinski\u00a0FC, Kaestner\u00a0F, Schafers\u00a0HJ et\u00a0al (2016) Outcome of patients with interstitial lung disease treated with extracorporeal membrane oxygenation for acute respiratory failure. Am J Respir Crit Care Med 193:527\u2013533","journal-title":"Am J Respir Crit Care Med"},{"key":"687_CR66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.04290417","volume":"13","author":"EE Van Daalen","year":"2018","unstructured":"Van Daalen\u00a0EE, Jennette\u00a0JC, Mcadoo\u00a0SP et al (2018) Predicting outcome in patients with anti-GBM glomerulonephritis. Clin J Am Soc Nephrol 13:63\u201372","journal-title":"Clin J Am Soc Nephrol"},{"key":"687_CR67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/MNH.0000000000000058","volume":"23","author":"M Walsh","year":"2014","unstructured":"Walsh\u00a0M (2014) Plasma exchange in antineutrophil cytoplasm antibody-associated vasculitis. Curr Opin Nephrol Hypertens 23:555\u2013559","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"687_CR68","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/ki.2013.131","volume":"84","author":"M Walsh","year":"2013","unstructured":"Walsh\u00a0M, Casian\u00a0A, Flossmann\u00a0O et al (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 84:397\u2013402. https:\/\/doi.org\/10.1038\/ki.2013.131 .","journal-title":"Kidney Int"},{"key":"687_CR69","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2010.10.049","volume":"57","author":"M Walsh","year":"2011","unstructured":"Walsh\u00a0M, Catapano\u00a0F, Szpirt\u00a0W et al (2011) Plasma exchange for renal vasculitis and idiopathic rapidly progressive glomerulonephritis: a\u00a0meta-analysis. Am J Kidney Dis 57:566\u2013574","journal-title":"Am J Kidney Dis"},{"key":"687_CR70","unstructured":"Walsh\u00a0M, Merkel\u00a0PA, Jayne\u00a0D (2018) The effects of plasma exchange and reduced-dose glucocorticoids during remission induction for treatment of severe ANCA-associated vasculitis. Arthritis Rheumatol 70(suppl 10). https:\/\/acrabstracts.org\/abstract\/the-effects-of-plasma-exchange-and-reduced-dose-glucocorticoids-during-remission-induction-for-severe-anca-associated-vasculitis\/ . Zugegriffen: 8. August 2019"},{"key":"687_CR71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","volume":"14","author":"M Walsh","year":"2013","unstructured":"Walsh\u00a0M, Merkel\u00a0PA, Peh\u00a0CA et al (2013) Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a\u00a0randomized controlled trial. Trials 14:73","journal-title":"Trials"},{"issue":"652","key":"687_CR72","first-page":"e659","volume":"30","author":"J Wang","year":"2015","unstructured":"Wang\u00a0J, Mcquilten\u00a0ZK, Wood\u00a0EM et\u00a0al (2015) Intravenous immunoglobulin in critically ill adults: When and what is the evidence? J\u00a0Crit Care 30(652):e659\u2013e616","journal-title":"J Crit Care"},{"key":"687_CR73","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s00393-016-0217-9","volume":"75","author":"T Witte","year":"2016","unstructured":"Witte\u00a0T (2016) Therapeutic administration of immunoglobulins. Z\u00a0Rheumatol 75:956\u2013963","journal-title":"Z Rheumatol"},{"key":"687_CR74","first-page":"1883","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates\u00a0M, Watts\u00a0RA, Bajema\u00a0IM et al (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75:1883\u20131894","journal-title":"Ann Rheum Dis"},{"key":"687_CR75","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2369-15-128","volume":"15","author":"YY Zhang","year":"2014","unstructured":"Zhang\u00a0YY, Tang\u00a0Z, Chen\u00a0DM et al (2014) Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol 15:128","journal-title":"BMC Nephrol"},{"key":"687_CR76","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2017.03.004","volume":"16","author":"AL Zignego","year":"2017","unstructured":"Zignego\u00a0AL, Ramos-Casals\u00a0M, Ferri\u00a0C et al (2017) International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev 16:523\u2013541","journal-title":"Autoimmun Rev"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-00687-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-019-00687-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-019-00687-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T20:35:24Z","timestamp":1695155724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-019-00687-0"}},"subtitle":["Rheumatische Systemerkrankungen auf der Intensivstation","Systemic rheumatic diseases in the intensive care unit"],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1007\/s00393-019-00687-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"29 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Hellmich hat Honorare f\u00fcr Beratungsleistungen oder f\u00fcr Vortr\u00e4ge von Abbvie, BMS, Chugai, Pfizer, InflaRx und Roche erhalten. C.\u00a0L\u00f6ffler gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}